Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Outterson, Kevin; Gopinathan, Unni; Clift, Charles; So, Anthony D; Morel, Chantal; Røttingen, John-Arne

doi:10.1371/journal.pmed.1002043

Scientific article

English

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

ContributorsOutterson, Kevin; Gopinathan, Unni; Clift, Charles; So, Anthony D; Morel, Chantal; Røttingen, John-Arne

Published inPLoS medicine, vol. 13, no. 6, e1002043

Publication date2016

Abstract

Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Résistance aux antibiotiques (866)

Citation (ISO format)

OUTTERSON, Kevin et al. Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. In: PLoS medicine, 2016, vol. 13, n° 6, p. e1002043. doi: 10.1371/journal.pmed.1002043

Article (Published version)

Identifiers

PID : unige:87647
DOI : 10.1371/journal.pmed.1002043
PMID : 27299990

Journal ISSN1549-1277

428views

207downloads

Creation29/08/2016 09:04:00

First validation29/08/2016 09:04:00

Update time08/10/2024 09:14:36

Status update08/10/2024 09:14:36

Last indexation31/10/2024 04:34:57

Archive ouverte UNIGE

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.

Technical informations